Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Med Decis Making. 2013 Nov 18;34(4):430–442. doi: 10.1177/0272989X13511705

Table 5.

Logistic-regression results for each “most important reason” (Non-standardized coefficients b (Standard Error (SE)) among those respondents not using cholesterol-lowering medication (n = 548). Significant predictors are in bold for emphasis.

Very serious muscle damage
B (SE) 		Prefer to avoid medications
B (SE) 		Serious side effects not likely
B (SE) 		Side effects not serious
B (SE) 		Too many side effects
B (SE) 		You don’t want to experience side effect
B (SE)
Constant −2.05 (.15) −1.19 (.11) −1.48 (.12) −1.60 (.14) −2.30 (.17) −3.75 (.50)
Numeric Format −.38 (.15) −.10 (.11) .20 (.12) .45 (.14) −.28 (.17) .89 (.50)
Numeracy −.06 (.08) .03 (.06) .12 (.07) −.17 (.08) −.17 (.09) −.04 (.32)
Age .43 (.21) .16 (.16) −.03 (.18) −.56 (.21) .35 (.24) −1.03 (.58)
Numeric Format * Numeracy .01 (.08) −.01 (.06) .06 (.07) .07 (.08) −.04 (.09) .01 (.32)
Numeric Format * Age −.07 (.21) .12 (.16) −.30 (.18) .00 (.21) −.09 (.24) 1.33 (.58)
Numeracy * Age .01 (.08) −.10 (.09) .02 (.10) −.08 (.11) .04 (.12) .16 (.34)
Numeric Format * Numeracy * Age −.21 (.11) .14 (.09) .06 (.10) .02 (.11) −.06 (.12) .18 (.34)
Nagelkerke R2=.06, χ2 (df=7) = 16.7, p=.02 Nagelkerke R2=.02, χ2 (df=7) = 6.8, p=.45 Nagelkerke R2=.04, χ2 (df=7) = 12.8, p=.08 Nagelkerke R2=.08, χ2 (df=7) = 28.8, p=.00 Nagelkerke R2=.04, χ2 (df=7) = 10.2, p=.18 Nagelkerke R2=.09, χ2 (df=7) = 16.6, p=.02